Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Rheumatology
Sort By
Newest First
1 / 1
1 / 1
Postmarketing Trial
FDA Responds to Safety Signal Reported in Required Postmarketing Trial for Xeljanz
U.S. Food & Drug Administration
PR-M02-19-NI-068
Feb 28, 2019
Rheumatology
Mallinckrodt Presents Data on H.P. Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2018 ACR/ARHP Annual Meeting
Mallinckrodt Pharmaceuticals
PR-M10-18-NI-092
Oct 26, 2018
Rheumatology
New Data Showcasing Lilly's Growing Commitment in Rheumatology to be Featured at the ACR/ARHP Annual Meeting
Eli Lilly and Company
PR-M10-18-NI-062
Oct 18, 2018
